In contrast to our study, previous reports demonstrated that deletion of the Cd44 gene inhibits initiation of colon carcinoma in Apc(Min/+) mice [61] and oncogenic progression in the testis of RHAMM-deficient mice [62]. This evidence concerns the gene CD44 and colon carcinoma.